In support of these findings, blocking IFN signaling by genetic ablation of Stat1 in the KrasG12D-driven lung cancer mouse model resulted in a significantly increased overall survival in comparison to control KrasG12D mice (Supplementary Fig. 26c). The gene discussed is STAT1; the disease is lung cancer.